BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34671197)

  • 1. Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.
    Zhou Y; Liu S; Liu C; Yang J; Lin Q; Zheng S; Chen C; Zhou Q; Chen R
    Int J Biol Sci; 2021; 17(14):3760-3775. PubMed ID: 34671197
    [No Abstract]   [Full Text] [Related]  

  • 2. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
    Chen P; Wang Y; Li J; Bo X; Wang J; Nan L; Wang C; Ba Q; Liu H; Wang H
    Clin Transl Med; 2021 Jun; 11(6):e462. PubMed ID: 34185421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis-specific targets in a patient with small intestinal neuroendocrine cancer.
    Rao M; Oh K; Moffitt R; Thompson P; Li J; Liu J; Sasson A; Georgakis G; Kim J; Choi M; Powers S
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32054662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
    Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ
    Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
    Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
    Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
    Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
    Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
    Saller J; Seydafkan S; Shahid M; Gadara M; Cives M; Eschrich SA; Boulware D; Strosberg JR; Aejaz N; Coppola D
    Cancer Genomics Proteomics; 2019; 16(5):309-318. PubMed ID: 31467225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.
    Miki M; Oono T; Fujimori N; Takaoka T; Kawabe K; Miyasaka Y; Ohtsuka T; Saito D; Nakamura M; Ohkawa Y; Oda Y; Suyama M; Ito T; Ogawa Y
    Cancer Med; 2019 Jul; 8(8):3748-3760. PubMed ID: 31129920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
    Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data.
    Davis-Marcisak EF; Sherman TD; Orugunta P; Stein-O'Brien GL; Puram SV; Roussos Torres ET; Hopkins AC; Jaffee EM; Favorov AV; Afsari B; Goff LA; Fertig EJ
    Cancer Res; 2019 Oct; 79(19):5102-5112. PubMed ID: 31337651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors.
    Yan N; Xie W; Wang D; Fang Q; Guo J; Chen Y; Li X; Gong L; Wang J; Guo W; Zhang X; Zhang Y; Gu J; Li C
    Genome Med; 2024 Jan; 16(1):2. PubMed ID: 38167466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing in cancer research.
    Zhang Y; Wang D; Peng M; Tang L; Ouyang J; Xiong F; Guo C; Tang Y; Zhou Y; Liao Q; Wu X; Wang H; Yu J; Li Y; Li X; Li G; Zeng Z; Tan Y; Xiong W
    J Exp Clin Cancer Res; 2021 Mar; 40(1):81. PubMed ID: 33648534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
    Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
    Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
    Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model.
    Wang Y; Tian X; Ai D
    Biomed Res Int; 2021; 2021():9919080. PubMed ID: 34095314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing.
    Cao YH; Ding J; Tang QH; Zhang J; Huang ZY; Tang XM; Liu JB; Ma YS; Fu D
    Bioengineered; 2022; 13(7-12):14974-14986. PubMed ID: 37105769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.